SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-22-014888
Filing Date
2022-03-24
Accepted
2022-03-24 16:47:34
Documents
56
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2021_orionbiotech.htm   iXBRL 10-K 1383490
2 DESCRIPTION OF SECURITIES f10k2021ex4-1_orionbiotech.htm EX-4.1 235866
3 CERTIFICATION f10k2021ex31-1_orionbiotech.htm EX-31.1 6431
4 CERTIFICATION f10k2021ex31-2_orionbiotech.htm EX-31.2 6459
5 CERTIFICATION f10k2021ex32-1_orionbiotech.htm EX-32.1 4286
6 CERTIFICATION f10k2021ex32-2_orionbiotech.htm EX-32.2 4405
  Complete submission text file 0001213900-22-014888.txt   4744233

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE oria-20211231.xsd EX-101.SCH 49426
8 XBRL CALCULATION FILE oria-20211231_cal.xml EX-101.CAL 20717
9 XBRL DEFINITION FILE oria-20211231_def.xml EX-101.DEF 207590
10 XBRL LABEL FILE oria-20211231_lab.xml EX-101.LAB 361386
11 XBRL PRESENTATION FILE oria-20211231_pre.xml EX-101.PRE 213987
50 EXTRACTED XBRL INSTANCE DOCUMENT f10k2021_orionbiotech_htm.xml XML 320531
Mailing Address ONE VANDERBILT AVENUE, 26TH FLOOR NEW YORK NY 10017
Business Address ONE VANDERBILT AVENUE, 26TH FLOOR NEW YORK NY 10017 212-303-7822
Orion Biotech Opportunities Corp. (Filer) CIK: 0001847416 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40410 | Film No.: 22767072
SIC: 6770 Blank Checks
Office of Real Estate & Construction